Toxicological Research : eISSN 2234-2753 / pISSN 1976-8257

Fig. 8.

Download original image
Fig. 8. Mouse lung sections after nBC100 and Avicel100 treatments during 6 months (400x magnification, scale = 20 μm). nBC100 group presented moderate diffuse degeneration of terminal bronchioles, multifocal medial hypertrophy of pulmonary arteries (marked with an arrow) and moderate multifocal to coalescing chronic bronchioloalveolar inflammation, composed of macrophages, lymphocytes and plasma cells, whereas Avicel100 group showed mild diffuse degeneration of terminal bronchioles and mild multifocal chronic bronchioloalveolar inflammation with inflammatory infiltrates similar to those observed with nBC100.
Toxicological Research 2019;35:45~63 https://doi.org/10.5487/TR.2019.35.1.045
© ToxicolRes